CA2410939C - Materials and methods for the treatment of gastroesophageal reflux disease - Google Patents
Materials and methods for the treatment of gastroesophageal reflux disease Download PDFInfo
- Publication number
- CA2410939C CA2410939C CA2410939A CA2410939A CA2410939C CA 2410939 C CA2410939 C CA 2410939C CA 2410939 A CA2410939 A CA 2410939A CA 2410939 A CA2410939 A CA 2410939A CA 2410939 C CA2410939 C CA 2410939C
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- compounds
- disorders
- compound according
- cisapride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20992600P | 2000-06-07 | 2000-06-07 | |
US60/209,926 | 2000-06-07 | ||
PCT/US2001/018365 WO2001093849A2 (en) | 2000-06-07 | 2001-06-07 | Treatment of gastroesophageal reflux disease using piperidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2410939A1 CA2410939A1 (en) | 2001-12-13 |
CA2410939C true CA2410939C (en) | 2010-02-16 |
Family
ID=22780902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2410939A Expired - Fee Related CA2410939C (en) | 2000-06-07 | 2001-06-07 | Materials and methods for the treatment of gastroesophageal reflux disease |
Country Status (6)
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6663639B1 (en) * | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US7846180B2 (en) | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
US8287554B2 (en) * | 1999-06-22 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Method and devices for tissue reconfiguration |
US6821285B2 (en) * | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US6750238B1 (en) | 2000-05-12 | 2004-06-15 | The University Of Toledo | Aralkyl ester soft drugs |
US7049326B2 (en) | 2000-05-12 | 2006-05-23 | The University Of Toledo | Method and compositions for temporarily incapacitating subjects |
AU2004268641A1 (en) * | 2003-08-29 | 2005-03-10 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastrointestinal motility disorders |
EP1701951B1 (en) | 2003-12-23 | 2010-02-10 | Serodus AS | Modulators of peripheral 5-ht receptors |
DE602005020580D1 (de) * | 2004-01-07 | 2010-05-27 | Aryx Therapeutics | Stereoisomere verbindungen und verfahren zur behandlung von erkrankungen des magen-darm-trakts und des zentralen nervensystems |
US8138204B2 (en) | 2004-01-07 | 2012-03-20 | Aryx Therapeutics, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
US8524736B2 (en) | 2004-01-07 | 2013-09-03 | Armetheon, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
MY147756A (en) * | 2005-05-25 | 2013-01-15 | Theravance Inc | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
CA2620379C (en) | 2005-08-31 | 2015-02-24 | Aryx Therapeutics, Inc. | Synthetic methods and intermediates for stereoisomeric compounds useful for the treatment of gastrointestinal and central nervous system disorders |
US20080085915A1 (en) * | 2006-06-23 | 2008-04-10 | Cyrus Becker | Compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
KR100976063B1 (ko) * | 2007-03-16 | 2010-08-17 | 동아제약주식회사 | 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법 |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
KR20100026641A (ko) * | 2008-09-01 | 2010-03-10 | 동아제약주식회사 | 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법 |
JP5845263B2 (ja) | 2010-09-01 | 2016-01-20 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap | 5−ht2b受容体アンタゴニスト |
JP6260531B2 (ja) * | 2012-05-17 | 2018-01-17 | Jsr株式会社 | 酸拡散制御剤、感放射線性樹脂組成物及びレジストパターン形成方法 |
US10570127B1 (en) | 2018-11-05 | 2020-02-25 | Renexxion, Llc | Material and methods for the treatment of gastro-intestinal disorders |
CN112816528B (zh) * | 2021-02-01 | 2024-04-09 | 合肥艾创微电子科技有限公司 | 一种感知存储集成式仿生触觉纤维及其制备方法 |
CN112966411B (zh) * | 2021-02-07 | 2022-05-24 | 华南理工大学 | 一种基于体代表单元应力的医疗植入件及制备方法与应用 |
CN113581374B (zh) * | 2021-08-25 | 2023-01-10 | 杭州海斗量海洋仪器有限公司 | 一种用于防护监测设备的浮标 |
CN115935635B (zh) * | 2022-11-29 | 2024-02-27 | 上海玫克生储能科技有限公司 | 基于电化学模型的锂电池路端电压计算方法、装置及介质 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE35550B1 (en) * | 1970-09-03 | 1976-03-18 | Wyeth John & Brother Ltd | Amino-and acylamino-pyridine and -hydropyridine derivatives |
GB1425706A (en) * | 1972-06-30 | 1976-02-18 | Wyeth John & Brother Ltd | Piperidine derivatives |
US4962115A (en) | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
CA1183847A (en) * | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US5057525A (en) | 1981-10-01 | 1991-10-15 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives |
CA1317940C (en) * | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
US5395832A (en) | 1991-02-15 | 1995-03-07 | Hokuriku Seiyaku Co., Ltd. | Benzamide derivatives |
JP3104142B2 (ja) * | 1991-02-15 | 2000-10-30 | 北陸製薬株式会社 | ベンズアミド誘導体 |
TW213460B (US06552046-20030422-C00009.png) * | 1991-02-15 | 1993-09-21 | Hokuriku Pharmaceutical | |
IT1260485B (it) * | 1992-05-29 | 1996-04-09 | Procedimento e dispositivo per il trattamento dell'obesita' di un paziente | |
CA2148700A1 (en) * | 1992-11-05 | 1994-05-11 | Laramie Mary Gaster | Piperidine derivatives as 5-ht4 receptor antagonists |
EP1000029B1 (en) * | 1997-07-11 | 2003-10-01 | Janssen Pharmaceutica N.V. | (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
JPH11292846A (ja) * | 1998-02-10 | 1999-10-26 | Hokuriku Seiyaku Co Ltd | ベンズアミド誘導体及びそれを含有する医薬 |
JP3398111B2 (ja) * | 1999-02-04 | 2003-04-21 | 北陸製薬株式会社 | ベンズアミド誘導体及びそれを含有する医薬 |
AR022338A1 (es) | 1999-02-04 | 2002-09-04 | Hokuriku Pharmaceutical | Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal. |
DE19933926A1 (de) * | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Pharma | Biphenylderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
US20040092511A1 (en) * | 1999-12-10 | 2004-05-13 | Billstein Stephan Anthony | Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
-
2001
- 2001-06-07 JP JP2002501422A patent/JP4584534B2/ja not_active Expired - Fee Related
- 2001-06-07 US US09/876,698 patent/US6552046B2/en not_active Ceased
- 2001-06-07 WO PCT/US2001/018365 patent/WO2001093849A2/en active IP Right Grant
- 2001-06-07 AU AU2001275326A patent/AU2001275326C1/en not_active Ceased
- 2001-06-07 EP EP01942028A patent/EP1296684A2/en not_active Ceased
- 2001-06-07 CA CA2410939A patent/CA2410939C/en not_active Expired - Fee Related
- 2001-06-07 AU AU7532601A patent/AU7532601A/xx active Pending
-
2003
- 2003-04-18 US US10/418,842 patent/US20030216387A1/en not_active Abandoned
-
2007
- 2007-12-21 US US11/962,592 patent/USRE42412E1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1296684A2 (en) | 2003-04-02 |
WO2001093849A2 (en) | 2001-12-13 |
CA2410939A1 (en) | 2001-12-13 |
US6552046B2 (en) | 2003-04-22 |
AU2001275326B2 (en) | 2006-02-02 |
JP4584534B2 (ja) | 2010-11-24 |
US20030216387A1 (en) | 2003-11-20 |
AU2001275326C1 (en) | 2006-09-21 |
JP2003535128A (ja) | 2003-11-25 |
US20020025970A1 (en) | 2002-02-28 |
USRE42412E1 (en) | 2011-05-31 |
WO2001093849A3 (en) | 2003-01-30 |
AU7532601A (en) | 2001-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE42412E1 (en) | Materials and methods for the treatment of gastroesophageal reflux disease | |
AU2001275326A1 (en) | Treatment of gastroesophageal reflux disease using piperidine derivatives | |
JP5200288B2 (ja) | 胃腸疾患および中枢神経系疾患の治療のための立体異性体化合物と方法 | |
US5070087A (en) | Aryl(alkyland alkylene)-N-((phenoxy and phenylthio)alkyl) aminoheterocyclics as cardiovascular, anthihistaminic, antisecretory and antiallergy agents | |
US4891376A (en) | 1-((2-Pyrimidinyl)aminoalkyl)piperidines, their preparation and their application in therapy | |
AU1311095A (en) | Novel heterocyclic compounds | |
CZ291294B6 (cs) | Nové heterocyklické sloučeniny | |
US20080085915A1 (en) | Compounds and methods for the treatment of gastrointestinal and central nervous system disorders | |
CN101258145A (zh) | 立体异构吡啶基和吡啶酮基化合物以及治疗胃肠和中枢神经系统疾病的方法 | |
WO1996031470A1 (en) | Novel heterocyclic compounds | |
EP1097924B1 (en) | 4-hydroxy-4-phenylpiperidine derivatives having opioid agonist activity and pharmaceuticals containing the same | |
AU2006201053B2 (en) | Materials and methods for the treatment of gastroesophageal reflux disease | |
EP1785415B1 (en) | Piperidine derivative or pharmaceutically acceptable salt thereof | |
WO1996031500A1 (en) | Novel heterocyclic compounds | |
EP0820443B1 (en) | Heterocyclic compounds for treating diabetes | |
WO1996031473A1 (en) | Novel heterocyclic compounds | |
JP3113447B2 (ja) | アミノカルボン酸誘導体、その製造方法および用途 | |
WO1996031474A1 (en) | Novel heterocyclic compounds | |
EP0825984A1 (en) | Novel method | |
WO1996031503A1 (en) | Novel heterocyclic compounds | |
BRPI0609312A2 (pt) | cicloexano-1,4-diaminas substituìdas por piperidinila | |
CA2217202A1 (en) | Novel heterocyclic compounds | |
MXPA03007967A (es) | Dimetil-(1-(1-fenil-ciclohexil)-pireridin-3-ilmetil)-aminas sustituidas y su uso como analgesicos. | |
WO1996031483A1 (en) | Novel heterocyclic compounds | |
WO1996031460A1 (en) | Novel heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20130607 |